• PDtrials - Parkinson's Disease Clinical Trials
• /Browse By Symptom
• /Study does not address symptoms

Official Study Title: Cognitive  CognitiveRelated to mental activities having to do with perception, memory, judgment, and reasoning. Impairment and Cognitive Training among Persons with Parkinson's Disease
Sponsor: University of South Florida (USF)
Clinicaltrials.gov ID:
Study ID:

Summary

The purpose of this study is to explore how cognitive abilities, such as mental quickness, memory, attention, and everyday activities, are affected by Parkinson's disease  Parkinson's DiseaseA chronic, slowly progressive disease of the nervous system characterized by the combination of tremor, rigidity, bradykinesia and stooped posture, among other symptoms. (PD). The researchers will be using the results of this study to develop and test cognitive training programs (which are non-invasive and non-pharmacological). The ultimate goal of the research is to help people with PD maintain their functioning and independence. Participation involves one to two testing sessions, which will take place at the University of South Florida (USF) Cognitive Aging Lab, the USF Movement Disorders Clinic in Tampa, or an approved off-site location. Each session will last between 45 minutes to 1½ hours and will be scheduled at times convenient to the participant. During these sessions, participants will answer questions about their PD diagnosis. Participants will also be asked to read eye charts, complete paper-and-pencil tests of memory and reasoning, and respond to a visual attention task on the computer. No computer experience is necessary, and a research assistant will provide guidance throughout each procedure. Some participants may be invited to complete a cognitive training program at a later date.

Study Phase

Phase 1
What is a study phase?

Symptoms Addressed: Non-movement Symptoms

Memory

Time Commitment

• Less than six months
• Two initial appointments.

Eligibility

• Gender(s) Accepted: Either

Inclusion Criteria

• 45 years of age or older
• Corrected visual acuity of 20/70 or better
• English-speaking
• Clinical  ClinicalDealing with or based on observation and treatment of people, as opposed to basic science carried out in the laboratory or in animals. diagnosis of PD

Exclusion Criteria

• Severe dementia

Enrollment

Expected Enrollment: 100 (US)
Date Enrollment Began: Oct 2007
Date Enrollment Ends: Sep 2010
Last Updated Date: Sep 28 2009
Trial Post Date: Jan 14 2008
Website:

Primary Contacts and Locations

Florida

• USF Cognitive Aging Lab
  coglabpd@yahoo.com
  Phone: (813) 974-6703
  School of Aging Studies
  13301 Bruce B. Downs Blvd., MHC 1304
  Tampa, FL 33612
  USA
  

View All Locations and Contacts